Kampo Yokukansan

Yokukansan acts primarily as a 5-HT1A receptor agonist, with geissoschizine methyl ether from Uncaria hooks modulating serotonin signaling in the brain. This mechanism helps regulate mood, anxiety, and behavioral symptoms. The formula also contains atractylenolide and glycyrrhizin, which contribute anti-inflammatory and neuroprotective effects. This multi-target approach may explain its benefits for irritability and agitation in dementia patients (Evidence Level C).

Yokukansan may interact with medications affecting potassium levels or liver function. The formula contains licorice (Glycyrrhiza), which can cause pseudoaldosteronism and should be used cautiously with diuretics, corticosteroids, digoxin, or other drugs that lower potassium. Patients taking hepatotoxic medications or those with existing liver disease should avoid this formula. Always consult a qualified Kampo practitioner before combining with prescription medications.

Standard Yokukansan dosage follows traditional Kampo prescribing, typically administered as a dried extract in divided doses two to three times daily. Adult dosing is determined by a qualified Kampo physician based on individual constitution and symptoms. The formula is usually taken before or between meals. Dosage adjustments may be necessary for elderly patients or those with compromised liver or kidney function.

Yokukansan is generally considered safe during pregnancy when prescribed by a qualified Kampo practitioner. The formula has a long history of traditional use without documented pregnancy-related adverse effects. However, pregnant and breastfeeding women should only use this formula under professional supervision. The presence of licorice requires monitoring for potential potassium depletion during extended use in any population.

Yokukansan is traditionally used for irritability, insomnia, emotional instability, and childhood night crying. Modern research has investigated its use for behavioral and psychological symptoms of dementia, including agitation and aggression. Clinical evidence supports its potential benefits for these conditions, though most studies show moderate-quality evidence (Level C). The formula is prescribed by Kampo practitioners based on individual symptom patterns rather than specific disease diagnoses.

The primary side effects of Yokukansan relate to its licorice content, which can cause hypokalemia (low potassium) and pseudoaldosteronism with prolonged use. Symptoms may include muscle weakness, fatigue, and elevated blood pressure. Patients with existing hypokalemia or liver disease should avoid this formula. Regular monitoring of potassium levels may be recommended during extended treatment. Most adverse effects are reversible upon discontinuation.